JG
COGT icon

Jain Global’s Cogent Biosciences COGT Stock Holding History

Jain Global’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
+35,014
New +$1.23M 0.01% 884
2026
Q1 		– Sell
-48,079
Closed -$1.71M – 1278
2025
Q4 		$1.71M Buy
+48,079
New +$1.35M 0.01% 617

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jain Global's COGT Position: Q2 2026 in Review

Jain Global opened a new position in Cogent Biosciences (COGT) in Q2 2026: 35,014 shares worth $1.36M. The stake represents 0.01% of the portfolio and ranks #884 among its holdings. This is a return to the name: Jain Global previously reported a position in COGT as recently as Q4 2025.

Jain Global first reported a position in COGT in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.71M in Q4 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Jain Global held 35,014 shares of Cogent Biosciences worth $1.36M as of Q2 2026.
  • Cogent Biosciences was a new Jain Global position in Q2 2026.
  • Cogent Biosciences made up 0.01% of Jain Global's portfolio in Q2 2026, its #884 holding.
  • Jain Global first reported a position in Cogent Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Jain Global's Cogent Biosciences position peaked at $1.71M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.